empty
 
 
pt
Pesquisar
Suporte
Abertura instanânea da conta
Plataforma de negociação
Depósito/Retirada
Pesquisar
Para Iniciantes Para Traders Para Parceiros Relaxe Sobre a InstaSpot
pt
#ALNY Voltar à lista de instrumentos #AUPH

Conversor de moedas

Amgen Inc.
279.77 USD
26 Nov 2024 22:59
Mudança de preço (% chg)
$-0.04
(-0.01%)
Fechamento anterior
Fechamento anterior

Preço de fechamento, no dia anterior.
$293.3
Abrir
Abrir

Preço de abertura.
$293.93
Máximo do dia
Máximo do dia

O preço mais alto do último dia de negociação.
$280.4
Mínimo do dia
Mínimo do dia

O preço mais baixo do último dia de negociação
$257.69
Alta de 52-semanas
Alta de 52-semanas

Faixa de preço alta nas últimas 52 semanas
$280.95
Baixa de 52-semana
Baixa de 52-semana

Faixa de preço baixa nas últimas 52 semanas
$257.69
Baixar arquivo
Buy
279.77
Sell
279.77
Open the chart in full screen view
Buy
279.77
Sell
279.77
Baixar arquivo
Open the chart in full screen view

About Amgen Inc.

Amgen Inc. is one of the world's leading biotechnology companies. Founded in 1980 in the United States, it currently operates in more than 70 countries around the world.

Amgen focuses on developing cutting-edge medicines against cancer, cardiovascular diseases, bone ailments, kidney diseases and other afflictions.

The company currently has a market capitalization of $122.5 billion. Amgen reported revenues of $25.98 billion and a net income of $5.89 billion in 2021.

Amgen Inc. stock and what affects it

The company stock is listed on the NASDAQ exchange under the ticker name AMGN. When the company had its initial public offering in 1983, its shares were priced between $16 and $19 at the time.

Now, Amgen's shares are trading between $227 and $231. Last year, it fluctuated from $198 to $258. Forecasts suggest the stock will continue to climb.

When trading this asset, you have to keep the following things in mind:

  • The company has a dominant position in the market.
  • There are potential opportunities to capitalize on its products and strategic initiatives.
  • Threats to Amgen include its competition, government regulation, and the company’s dependence on wholesale distributors.

Não pode falar agora?
Faça sua pergunta no chat.